Fourth quarter net revenue of $153 million, up 24% year-over-yearFourth quarter adjusted EBITDA of $13 millionFourth quarter net income of $6 million and fourth quarter adjusted net income of $12 millionFull year net revenue of $810 million, up 25% year-over-yearFull year adjusted EBITDA of $163 millionFull year net operating cash flow of $88 million and free cash flow of $84 million NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the four ...

DALLAS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Spring Valley Acquisition Corp. IV (the “Company”) announced today that, commencing on or about Monday, March 2, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares and warrants included in the units. The Class A ordinary shares and warrants that are separated are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “SVIV” and “SVIVW”, respectively. Any units not sep ...

WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will be participating in the following upcoming investor conferences in March: TD Cowen 46th Annual Health Care Conference, Boston, MAWednesday, March 4, 2026, Fireside Chat - 9:50 a.m. ET2026 Leerink Partners Global ...

VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sable Resources Ltd. ("Sable" or the "Company") (TSXV: SAE | OTCQB: SBLRF) is pleased to report the discovery of a new copper-mineralized zone, named Zorro North, located approximately 1.5 km northwest of the previously defined Zorro Cu target, at the Zorro Project in San Juan Province, Argentina (Figure 1). Sable’s previously released results from the Zorro Cu and Zorro Veins targets returned values up to 4.38% Cu, 140 g/t Au, and 584 g/t Ag (s ...

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; expect moderating revenue growth in 2026 TEBE-AM enrollment completion anticipated 1H 2026 with topline data expected as early as 2H 2026 PRAME franchise Phase 1/2 data to be presented in 2H 2026: brenetafusp in ovarian and lung cancer, and initial data with half-life extended candidate (IMC-P115C) Additional ...

WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that the Company will participate in a hybrid presentation followed by an analyst-led Q&A session at the TD Cowen 46th Annual Health Care Conference being held at the Boston Marriott Copley Place in Boston, MA on Wednesday, March 4, 20 ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines to treat brain disorders and symptoms caused by excess neural excitability, today announced that the Company’s management will participate in three upcoming investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences Conference – Wednesday, February 25th at 11:20 am ET46th Annual TD Cowen Health Care Conference – Wednesday, March 4th at 9:50 am ETLeeri ...

First‑time outsourced operations for Europe’s leading lingerie brand, delivering a streamlined, technology‑driven, multi‑channel logistics solution ALMERE, The Netherlands, Feb. 25, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure‑play contract logistics provider, today announced the successful launch of its new partnership with Hunkemöller, one of Europe’s leading lingerie brands. GXO began managing Hunkemöller’s logistics operations in Almere as of January 1, 2026, markin ...

BROOKFIELD, Conn., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its first quarter of fiscal year 2026 ended February 1, 2026. Commenting on the first quarter performance, Chairman and CEO George Macricostas said, “Photronics delivered strong results in our fiscal first quarter achieving record high-end IC revenue for the second consecutive quarter. We remain on track with our facility expans ...

MONTVALE, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corp ...